On 31 March 2022, Dr Anna McLean presented her research on tumour growth in patients with neurofibromatosis type 2 at an international neurosurgery training course in Limassol, Cyprus. More specifically, it was about the growth of intramedullary spinal tumours. Usually, in NF2, these are ependymomas. These are mostly benign, slow-growing tumours, but they can lead to a variety of serious symptoms. Dr. McLean was able to show through her measurements that half of all patients with NF2 have such tumours and that these tumours grow significantly after an average of two years. Therefore, the follow-up every two years should also include the spinal axis.
About 150 international neurosurgeons listened to these presentations and showed great interest in a lively discussion. There was also an opportunity to promote the Merlin Foundation and associated books.
As a special award, Dr McLean received an EANS award for the best trainee lecture. You can read her slides here.